- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.93 | 1.9 |
NAV | ₹37.85 | ₹38.59 |
Fund Started | 12 Nov 2018 | 25 Jun 2018 |
Fund Size | ₹2961.36 Cr | ₹5507.52 Cr |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.93
1.9
NAV
₹37.85
₹38.59
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹2961.36 Cr
₹5507.52 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 14.99% | 20.37% |
3 Year | 26.11% | 29.86% |
5 Year | 22.71% | 24.19% |
1 Year
14.99%
20.37%
3 Year
26.11%
29.86%
5 Year
22.71%
24.19%
Holding Analysis
Equity | 99.05% | 96.99% |
Cash | 0.95% | 3.01% |
Equity
99.05%
96.99%
Cash
0.95%
3.01%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Cipla Ltd. | 8.86% |
Cohance Lifesciences Ltd. | 8.81% |
Sun Pharmaceutical Industries Ltd. | 8.70% |
Ipca Laboratories Ltd. | 8.16% |
Gland Pharma Ltd. | 4.94% |
Alembic Pharmaceuticals Ltd. | 4.91% |
Globus Medical Inc | 4.59% |
Laurus Labs Ltd. | 4.57% |
Apollo Hospitals Enterprise Ltd. | 4.53% |
Sai Life Sciences Ltd. | 4.08% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.66% |
Dr. Reddy's Laboratories Ltd. | 9.66% |
Divi's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 7.85% |
Aurobindo Pharma Ltd. | 6.34% |
Alkem Laboratories Ltd. | 4.12% |
Zydus Lifesciences Ltd. | 4.01% |
Lupin Ltd. | 3.98% |
Gland Pharma Ltd. | 3.95% |
Syngene International Ltd. | 2.46% |
Fund Manager
Name | Jay Kothari | Dharmesh Kakkad |
Start Date | 16 Mar 2018 | 23 Feb 2021 |
Name
Jay Kothari
Dharmesh Kakkad
Start Date
16 Mar 2018
23 Feb 2021
About Fund
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 12 Nov 2018 | 25 Jun 2018 |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018